Content area

Abstract

The hippocampus is one of the most affected areas in Alzheimer’s disease (AD)1. Moreover, this structure hosts one of the most unique phenomena of the adult mammalian brain, namely, the addition of new neurons throughout life2. This process, called adult hippocampal neurogenesis (AHN), confers an unparalleled degree of plasticity to the entire hippocampal circuitry3,4. Nonetheless, direct evidence of AHN in humans has remained elusive. Thus, determining whether new neurons are continuously incorporated into the human dentate gyrus (DG) during physiological and pathological aging is a crucial question with outstanding therapeutic potential. By combining human brain samples obtained under tightly controlled conditions and state-of-the-art tissue processing methods, we identified thousands of immature neurons in the DG of neurologically healthy human subjects up to the ninth decade of life. These neurons exhibited variable degrees of maturation along differentiation stages of AHN. In sharp contrast, the number and maturation of these neurons progressively declined as AD advanced. These results demonstrate the persistence of AHN during both physiological and pathological aging in humans and provide evidence for impaired neurogenesis as a potentially relevant mechanism underlying memory deficits in AD that might be amenable to novel therapeutic strategies.

Newborn neurons are continuously incorporated into the healthy adult human hippocampus up to the ninth decade of life. However, robust adult hippocampal neurogenesis sharply declines during the progression of Alzheimer’s disease.

Details

Title
Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease
Author
Moreno-Jiménez, Elena P 1 ; Flor-García, Miguel 1 ; Terreros-Roncal, Julia 1 ; Rábano Alberto 2 ; Cafini Fabio 3 ; Pallas-Bazarra Noemí 4   VIAFID ORCID Logo  ; Ávila Jesús 4 ; Llorens-Martín María 1   VIAFID ORCID Logo 

 Centro de Biología Molecular ‘Severo Ochoa’, CBMSO, CSIC-UAM, Department of Molecular Neuropathology, Madrid, Spain (GRID:grid.465524.4); Universidad Autónoma de Madrid, Department of Molecular Biology, Faculty of Sciences, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126); Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
 CIEN Foundation, Neuropathology Department, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
 Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Madrid, Spain (GRID:grid.119375.8) (ISNI:0000000121738416) 
 Centro de Biología Molecular ‘Severo Ochoa’, CBMSO, CSIC-UAM, Department of Molecular Neuropathology, Madrid, Spain (GRID:grid.465524.4); Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
Pages
554-560
Publication year
2019
Publication date
Apr 2019
Publisher
Nature Publishing Group
ISSN
10788956
e-ISSN
1546170X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2203124905
Copyright
2019© The Author(s), under exclusive licence to Springer Nature America, Inc. 2019